Big Pharma spinout on Peninsula targets childhood liver diseases, $86M IPO

The Foster City-based spinout from Shire is targeting two drugs that its co-founder sold to Shire four years ago.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.